BUY Finolex Industries Limited — ICICI Securities
byICICI SecuritiesHorizon: NA (inferred 1 year)3 Nov 2026via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
3 other SEBI-registered advisors have active long-term BUY calls on this stock, all issued in the last 14 days
Advisor consensus · same horizon·3 Nov · 4d ago
Finolex Industries Q2: Revenue rises 27% on 28% volume growth, EBITDA declines
NewsCnbc-Tv18·30 Oct · 1w ago
Finolex Industries Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
NSE · Outcome of Board Meeting·30 Oct · 1w ago
Long-term trend bearish — 200-day average falling over the past quarter
Technicals · trend·6 Nov · yesterday
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Finolex Industries
- BUY — IDBI Capital3 Nov 2026 · ~1 year · target ₹174 · Active
- BUY — Jefferies India3 Nov 2026 · ~1 year · target ₹180 · Active
- BUY — Prabhudas Lilladher3 Nov 2026 · ~1 year · target ₹206 · Active
- BUY — Vikas Sethi, Sethi Finmart24 Aug 2026 · ~2 weeks · target ₹180 · Expired
- BUY — Mehul Kothari, Anand Rathi22 Aug 2026 · ~2 weeks · target ₹168 · SL hit
More from ICICI Securities
- BUY ICICI Bank5 Nov 2026 · ~1 year · target ₹1,800 · Active
- BUY Stylam Industries5 Nov 2026 · ~1 year · target ₹3,750 · Active
- BUY Emcure Pharmaceuticals5 Nov 2026 · ~1 year · target ₹2,560 · Active
- BUY Saregama India5 Nov 2026 · ~1 year · target ₹740 · Active
- BUY Procter & Gamble Health4 Nov 2026 · ~1 year · target ₹6,680 · Active

